IP Library Granted Patent US 9,511,102
Granted Patent B2
US 9,511,102 · App. 13/817,378 · Granted Dec 6, 2016

Probiotic composition for oral health

Inventor: Jordi Cuñé Castellana (Bellaterra, ES)
Assignee: AB-BIOTICS S.A.
A61K35/747A61K8/99A61Q11/00C12N1/20C12R1/24C12R1/25A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,511,102
App. No.
13/817,378
Granted
Dec 6, 2016
Kind
B2
Abstract

The present invention provides a composition comprising an effective amount of Lactobacillus plantarum CECT 7481 and Lactobacillus brevis CECT 7480. Said strains exhibit various functional properties that make them suitable for their use in the improvement of oral health. Such properties include not only good antagonistic properties against oral pathogens, but also the ability to colonize the oral cavity and a low acidification profile. The invention also provides for the use of said composition as a probiotic and/or a medicament for oral health applications as well as products containing said composition.

Claims (43)

1. A solid composition comprising

a cryoprotectant;

a freeze-dried bacterial biomass comprising at least one strain chosen from: (a) the isolated strain of Lactobacillus plantarum deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7481, and (b) the isolated strain of Lactobacillus brevis deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7480; and

a pharmaceutically acceptable carrier chosen from an emulsion, a gel, a paste, granules, a powder, and a gum.

2. An oral care product comprising an effective amount of the composition as defined in claim 1 .

3. The oral care product according to claim 2 , which is a chewing gum, a tooth paste, a mouth spray, a lozenge, or an oral dispersible tablet.

4. A pharmaceutical composition comprising an effective amount of the composition as defined in claim 1 and at least one pharmaceutically acceptable excipient.

5. The pharmaceutical composition according to claim 4 , which is a lozenge or an oral dispersible tablet.

6. An edible product comprising the composition as defined in claim 1 and at least one other edible ingredient.

7. The edible product of claim 6 , which is a lozenge or an oral dispersible tablet.

8. A dietary supplement comprising an effective amount of the composition as defined in claim 1 .

9. The dietary supplement of claim 8 , which is a lozenge or an oral dispersible tablet.

10. A cosmetic composition comprising the composition as defined in claim 1 and at least one cosmetically acceptable excipient.

11. The solid composition according to claim 1 , wherein the freeze-dried bacterial biomass comprises the isolated strain of Lactobacillus plantarum deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7481.

12. An oral care product comprising an effective amount of the composition as defined in claim 11 .

13. The oral care product according to claim 12 , which is a chewing gum, a tooth paste, a mouth spray, a lozenge, or an oral dispersible tablet.

14. A pharmaceutical composition comprising an effective amount of the composition as defined in claim 11 and at least one pharmaceutically acceptable excipient.

15. The pharmaceutical composition according to claim 14 , which is a lozenge or an oral dispersible tablet.

16. An edible product comprising the composition as defined in claim 11 and at least one other edible ingredient.

17. The edible product of claim 16 , which is a lozenge or an oral dispersible tablet.

18. A dietary supplement comprising an effective amount of the composition as defined in claim 11 .

19. The dietary supplement of claim 18 , which is a lozenge or an oral dispersible tablet.

20. A cosmetic composition comprising the composition as defined in claim 11 and at least one cosmetically acceptable excipient.

21. The solid composition according to claim 1 , wherein the freeze-dried bacterial biomass comprises the isolated strain of Lactobacillus brevis deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7480.

22. An oral care product comprising an effective amount of the composition as defined in claim 21 .

23. The oral care product according to claim 22 , which is a chewing gum, a tooth paste, a mouth spray, a lozenge, or an oral dispersible tablet.

24. A pharmaceutical composition comprising an effective amount of the composition as defined in claim 21 and at least one pharmaceutically acceptable excipient.

25. The pharmaceutical composition according to claim 24 , which is a lozenge or an oral dispersible tablet.

26. An edible product comprising the composition as defined in claim 21 and at least one other edible ingredient.

27. The edible product of claim 26 , which is a lozenge or an oral dispersible tablet.

28. A dietary supplement comprising an effective amount of the composition as defined in claim 21 .

29. The dietary supplement of claim 28 , which is a lozenge or an oral dispersible tablet.

30. A cosmetic composition comprising the composition as defined in claim 21 and at least one cosmetically acceptable excipient.

31. The solid composition according to claim 1 , wherein the freeze-dried bacterial biomass comprises the isolated strain of Lactobacillus plantarum deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7481 and the isolated strain of Lactobacillus brevis deposited in the Spanish Type Culture Collection (CECT) under accession number CECT 7480.

32. An oral care product comprising an effective amount of the composition as defined in claim 31 .

33. The oral care product according to claim 32 , which is a chewing gum, a tooth paste, a mouth spray, a lozenge, or an oral dispersible tablet.

34. A pharmaceutical composition comprising an effective amount of the composition as defined in claim 31 and at least one pharmaceutically acceptable excipient.

35. The pharmaceutical composition according to claim 34 , which is a lozenge or an oral dispersible tablet.

36. An edible product comprising the composition as defined in claim 31 and at least one other edible ingredient.

37. The edible product of claim 36 , which is a lozenge or an oral dispersible tablet.

38. A dietary supplement comprising an effective amount of the composition as defined in claim 31 .

39. The dietary supplement of claim 38 , which is a lozenge or an oral dispersible tablet.

40. A cosmetic composition comprising the composition as defined in claim 31 and at least one cosmetically acceptable excipient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2013
From: CUNE CASTELLANA, JORDI
To: AB-BIOTICS S.A.
Reel/Frame 029851/0104 →
Priority Claims (1)
EP 10173286 · Aug 18, 2010 · regional
Continuity (1)
Related Publication 20130209374A1 · Aug 15, 2013